MWA for breast cancer in 35 patients resulted in 32 patients having complete ablation of the tumor, with an increase in immune CD4+ T cell and IFN-γ compared to surgically resected tumors (n = 13) [105]. The gene discussed is CD4; the disease is breast cancer.